VHT Vanguard Health Care ETF


$ 272.61 $ 0.20 (0.07 %)    

Friday, 24-Oct-2025 17:13:04 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 272.65
$ 272.87
$ 272.14 x 2
$ 275.00 x 1
$ 272.53 - $ 273.92
$ 232.22 - $ 274.42
109,798
na
na
$ 0.68
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 how-trumps-shutdown-standoff-could-hand-health-care-etfs-a-lifeline

Trump's comments on health-care negotiations with Democrats can put ETFs like XLV, IHF, and XHS back on investors' rada...

 trump-admin-targets-medicaid-spending-on-immigrants-threatening-over-12-billion-california-program

The Trump administration is investigating Medicaid spending in California and other Democrat-led states over potential misuse i...

 rfk-jrs-massive-federal-health-workforce-cut-could-take-decades-to-rebuild-warn-experts-we-cannot-accurately-assess-whether-we-are-truly-making-america-healthier

Experts raise alarms about Health Secretary Robert F. Kennedy Jr's decision to layoff tens of thousands of federal workers,...

 as-trump-tariffs-spark-panic-investors-rush-into-these-5-recession-proof-etfs

ETFs that provide exposure to sectors that have historically been considered defensive during downturns are now in the limelight.

 nih-funding-cuts-to-spook-healthcare-stocks-rfk-jrs-confirmation-at-hhs-sparks-concerns-over-research-dollars-causing-uncertainty-says-analyst

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

 us-states-sue-national-institutes-of-health-over-4-billion-annual-cut-in-biomedical-research-grant-budget

A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set f...

 goldman-sachs-predicts-gradual-recovery-for-tools-and-contract-research-sector-in-2025-stable-large-pharma-spending-key-to-recovery

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved inv...

 sp-500-hits-57-all-time-highs-in-record-breaking-2024-magnificent-7-drive-30-of-nasdaqs-surge

The year of milestones, 2024, has seen an unperturbed rise in the bull market, we recap 2024's landmark junctures in the U....

 your-healthcare-costs-are-soaring-us-spending-reached-5-trillion-in-2023-with-major-increase-in-obesity-and-diabetes-drugs-hospital-services

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private i...

 fda-commissioner-califf-candid-on-trumps-impact-we-just-dont-know-whats-going-to-happen

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlight...

 auto-stocks-abortion-health-care-in-spotlight-at-dnc-joe-biden-uaw-president-women-affected-by-roe-v-wade-decision-headline-night-1

The first night of the Democratic National Convention (DNC) could have investors eyeing sectors like healthcare and automotive ...

 upward-trajectory-for-biotechpharma-ma-sector-trends-towards-pre-pandemic-levels-forecasts-positive-for-2024

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 bill...

 sp-500-stuck-in-4600-4800-limbo-for-2024-wells-fargo-pinpoints-3-favored-sectors-for-next-year

Wells Fargo Investment Institute has a 4600-4800 year-end 2024 target for the S&P 500 Index and 2000-2200 for the MSCI EAFE...

 analysis-autoworkers-are-a-missing-piece-in-the-october-jobs-report-heres-why-that-matters

While the markets are focussing on the October jobs report missing expectations, here's a missing piece that may prove them...

 lab-developed-tests-under-fda-scrutiny-what-it-means-for-startups

A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests ...

 from-ai-to-obesity-drugs---global-pharma-has-700b-for-ma-and-investments-goldman-sachs

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&...

Core News & Articles

The National Institutes of Health (NIH) has halted a trial evaluating the safety and effectiveness<

 white-house-says-administration-has-finalized-medical-insurance-transparency-rule

-Reuters

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION